Site Search
Search Results
Misuse of March-In Authority Could Jeopardize Progress in Cancer Research and Prove Ineffective in Intent to Lower Prescription Drug Prices
... innovations over the last 40 years. We share the Administration’s mission to lower drug costs, and no discovery that could improve public health should sit on a shelf or be inaccessible to the public. Nonetheless, we remain concerned about the effectiveness of utilizing march-in ...
ACS CAN members attend town hall call recapping outcome of 2018 election
... Bill spoke last week on ACS CAN’s members-only town hall call that broke down the election results and discussed how the results will affect health care and cancer issues around the country. Bill was joined on the call by ACS CAN volunteers and staff members who talked about Cancer Votes, ACS ...
One in Five People With Cancer Participate in Medical Research Studies
... in cancer research. This expanded analysis includes more than 70% of people diagnosed with cancer in the U.S. each year who received care at a variety of clinical settings, from community hospitals and academic medical centers to National Cancer Institute-designated comprehensive ... to patients, we need an inclusive, accurate assessment of current participation to inform these policies,” said Joseph Unger, PhD, MS, a health services researcher and biostatistician at Fred Hutch and lead author of the study. “While we knew that patients play a significant role ... studies were derived solely from government-sponsored trials, the study authors used patient data from a diverse range of trial sponsors and care settings for this analysis. Importantly, the data included settings such as community hospitals, where a majority of U.S. cancer patients ...
Hundreds of Cancer Patients, Survivors to Congress: Make Cancer a National Priority
... bills. The House Appropriations Committee already passed a bill that includes a $2 billion increase for the National Institutes of Health (NIH) and a $300 million increase for the National Cancer Institute (NCI). The Senate Appropriations Subcommittee on Labor Health and Human Services will mark-up its funding bill Tuesday. “Thanks to past federal investment in the fight against cancer, research keeps ... will also encourage lawmakers to advance legislation that supports patients’ quality of life by increasing access to palliative or supportive care, which can be provided at any age or stage of illness. They will ask Congress to close a Medicare loophole that often results in surprise ...
Bipartisan Legislation Aimed at Improving Access to Clinical Trials for Patients Introduced in the Senate
... income and does not count toward income eligibility for programs such as Medicaid. Additionally, the bill would allow the U.S. Department of Health and Human Services (HHS) to issue grants for community education, outreach and recruitment efforts to encourage more participation ... who are underrepresented in clinical trials. Grant-eligible activities would include working with local trial sites like community health centers, training health care personnel and clinical trial investigators, engaging community stakeholders to promote clinical trial participation and building partnerships ...
New Legislation Would Make It Easier for Patients to Participate in Clinical Trials
... clarifies that such support by sponsors is permitted under anti-kickback laws. In addition, the legislation would allow the U.S. Department of Health and Human Services (HHS) to provide grants for community education, outreach and recruitment activities to enable greater clinical trial ... who currently are underrepresented in clinical trials. Grant-eligible activities would include working with local trial sites like community health centers, training health care personnel and clinical trial investigators, engaging community stakeholders to encourage clinical trial participation and fostering ...
Cancer Advocates Call on Congressional Leadership to Advance Swift, Comprehensive Solution for Continued Drug Shortages
... drug shortage crisis continues to have a significant impact on cancer patients. One in every 10 cancer patients and survivors report impacts to care, a majority of whom have had difficulties finding substitute medications (68%) and cited treatment delays (59%), according to a recent survey ... there are 16 oncology drugs listed in the shortage , a number of which don’t have an effective alternative and have led to worse health outcomes for cancer patients. The full text of the letter can be read here. 0 American Cancer Society Cancer Action Network Issues ...
In a victory for cancer patients, new Medicare ruling protects timely drug access for current patients
On Thursday, the U.S. Department of Health and Human Services (HHS) announced its final ruling on changes to Medicare Part D regarding cancer patients’ access to lifesaving drugs. ... HHS ruling, current cancer patients with Medicare Part D won’t have to worry that their specialized cancer drug won’t be covered. “Cancer care is a race against time. We are glad HHS and Secretary Azar listened to the countless patients who voiced their serious concern over the ...
ACS CAN Calls on Congress to Reject Cuts; Draft Full Appropriations Bills That Include Increases to Protect Cancer Patients
... advocacy affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. We stand with our volunteers, working to make cancer a top priority for policymakers in cities, ...
Regional Eligibility Screening Nearly Doubles Cancer Clinical Trial Opportunities, May Increase Enrollment, New Papers Show
... creation of automated screening tools and processes that would be integrated into provider workflows, directly interfacing with site electronic health records, that would search for trial eligibility in a regional manner. “We’ve laid the foundation for a new way of thinking about ... Referral, and Operations: Findings from a Survey , sought to gain insight into cancer clinical trial enrollment practices through a survey of health care providers such as physicians and nurses. The survey looked at both opening and recruiting for onsite trials and referring to offsite trials. ...
Type
Priority Issue
State
- (-) Remove National filter National
- Georgia (2) Apply Georgia filter
- Minnesota (2) Apply Minnesota filter
- New Jersey (2) Apply New Jersey filter
- North Dakota (2) Apply North Dakota filter
- Tennessee (2) Apply Tennessee filter
- California (1) Apply California filter
- Kentucky (1) Apply Kentucky filter
- Mississippi (1) Apply Mississippi filter
- North Carolina (1) Apply North Carolina filter
- Oklahoma (1) Apply Oklahoma filter